119 related articles for article (PubMed ID: 18549684)
1. LH as a diagnostic criterion for polycystic ovary syndrome in patients with WHO II oligo/amenorrhoea.
Hendriks ML; Brouwer J; Hompes PG; Homburg R; Lambalk CB
Reprod Biomed Online; 2008 Jun; 16(6):765-71. PubMed ID: 18549684
[TBL] [Abstract][Full Text] [Related]
2. Women with oligo-/amenorrhoea and polycystic ovaries have identical responses to GnRH stimulation regardless of their androgen status: comparison of the Rotterdam and Androgen Excess Society diagnostic criteria.
Lewandowski KC; Cajdler-Luba A; Bieńkiewicz M; Lewiński A
Neuro Endocrinol Lett; 2011; 32(6):847-56. PubMed ID: 22286802
[TBL] [Abstract][Full Text] [Related]
3. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
Barber TM; Wass JA; McCarthy MI; Franks S
Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.
Sahmay S; Atakul N; Aydogan B; Aydin Y; Imamoglu M; Seyisoglu H
Acta Obstet Gynecol Scand; 2013 Dec; 92(12):1369-74. PubMed ID: 23980726
[TBL] [Abstract][Full Text] [Related]
5. The utility of the gonadotrophin releasing hormone (GnRH) test in the diagnosis of polycystic ovary syndrome (PCOS).
Lewandowski KC; Cajdler-Łuba A; Salata I; Bieńkiewicz M; Lewiński A
Endokrynol Pol; 2011; 62(2):120-8. PubMed ID: 21528473
[TBL] [Abstract][Full Text] [Related]
6. Endocrine features of polycystic ovary syndrome in a random population sample of 14-16 year old adolescents.
van Hooff MH; Voorhorst FJ; Kaptein MB; Hirasing RA; Koppenaal C; Schoemaker J
Hum Reprod; 1999 Sep; 14(9):2223-9. PubMed ID: 10469684
[TBL] [Abstract][Full Text] [Related]
7. LH pulsatility and response to a single s.c. injection of buserelin in polycystic ovary syndrome.
Prelević GM; Würzburger MI; Balint-Peric L
Gynecol Endocrinol; 1990 Mar; 4(1):1-13. PubMed ID: 2110712
[TBL] [Abstract][Full Text] [Related]
8. Variation of luteinizing hormone and androgens in oligomenorrhoea and its implications for the study of polycystic ovary syndrome.
van Hooff MH; van der Meer M; Lambalk CB; Schoemaker J
Hum Reprod; 1999 Jul; 14(7):1684-9. PubMed ID: 10402368
[TBL] [Abstract][Full Text] [Related]
9. Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome.
Pierre A; Peigné M; Grynberg M; Arouche N; Taieb J; Hesters L; Gonzalès J; Picard JY; Dewailly D; Fanchin R; Catteau-Jonard S; di Clemente N
Hum Reprod; 2013 Mar; 28(3):762-9. PubMed ID: 23321213
[TBL] [Abstract][Full Text] [Related]
10. The diagnosis of polycystic ovaries in women with oligo-amenorrhoea: predictive power of endocrine tests.
Fox R; Corrigan E; Thomas PA; Hull MG
Clin Endocrinol (Oxf); 1991 Feb; 34(2):127-31. PubMed ID: 2022063
[TBL] [Abstract][Full Text] [Related]
11. The phenotype of hirsute women: a comparison of polycystic ovary syndrome and 21-hydroxylase-deficient nonclassic adrenal hyperplasia.
Pall M; Azziz R; Beires J; Pignatelli D
Fertil Steril; 2010 Jul; 94(2):684-9. PubMed ID: 19726039
[TBL] [Abstract][Full Text] [Related]
12. Anti-Mullerian Hormone: an indicator for the severity of polycystic ovarian syndrome.
Köninger A; Koch L; Edimiris P; Enekwe A; Nagarajah J; Kasimir-Bauer S; Kimmig R; Strowitzki T; Schmidt B
Arch Gynecol Obstet; 2014 Nov; 290(5):1023-30. PubMed ID: 24961320
[TBL] [Abstract][Full Text] [Related]
13. The significance of a single serum LH measurement in women with cycle disturbances: discrepancies between immunoreactive and bioactive hormone estimates.
Fauser BC; Pache TD; Hop WC; de Jong FH; Dahl KD
Clin Endocrinol (Oxf); 1992 Nov; 37(5):445-52. PubMed ID: 1486695
[TBL] [Abstract][Full Text] [Related]
14. Inappropriate gonadotropin secretion in polycystic ovary syndrome.
Hsu MI; Liou TH; Liang SJ; Su HW; Wu CH; Hsu CS
Fertil Steril; 2009 Apr; 91(4):1168-74. PubMed ID: 18325508
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
[TBL] [Abstract][Full Text] [Related]
16. Polycystic ovary syndrome or hyperprolactinaemia: a study of mild hyperprolactinaemia.
Su HW; Chen CM; Chou SY; Liang SJ; Hsu CS; Hsu MI
Gynecol Endocrinol; 2011 Jan; 27(1):55-62. PubMed ID: 20504100
[TBL] [Abstract][Full Text] [Related]
17. The predictive power of endocrine tests for the diagnosis of polycystic ovaries in women with oligoamenorrhea.
Turhan NO; Toppare MF; Seçkin NC; Dilmen G
Gynecol Obstet Invest; 1999; 48(3):183-6. PubMed ID: 10545743
[TBL] [Abstract][Full Text] [Related]
18. [Preliminary study on the value of ratio of serum luteinizing hormone/follicle-stimulating hormone in diagnosis of polycystic ovarian syndrome among women with polycystic ovary].
Ma CS; Lin Y; Zhang CH; Xu H; Li YF; Zhang SC; Tan Y; Quan S; Xing FQ
Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):177-80. PubMed ID: 21575449
[TBL] [Abstract][Full Text] [Related]
19. Which hormone tests for the diagnosis of polycystic ovary syndrome?
Robinson S; Rodin DA; Deacon A; Wheeler MJ; Clayton RN
Br J Obstet Gynaecol; 1992 Mar; 99(3):232-8. PubMed ID: 1296589
[TBL] [Abstract][Full Text] [Related]
20. Oestrogen and androgen states in oligo-amenorrhoeic women with polycystic ovaries.
Fox R; Corrigan E; Thomas PG; Hull MG
Br J Obstet Gynaecol; 1991 Mar; 98(3):294-9. PubMed ID: 1827032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
